NMPA Approval

Tripelennamine Hydrochloride Tablets

Approval Number

国药准字H21023461

Company原研药港生物制药（沈阳）股份有限公司

Registration Date

August 18, 2021

Previous Approval Numbers

国药准字H21023461

Drug Information

Generic Name

盐酸曲吡那敏片

Dosage Form

片剂

Strength

25mg

Drug Type

化学药品

Registration Date

August 18, 2021

Company Information

Applicant Company

Company Name原研药港生物制药（沈阳）股份有限公司

Company Address

沈阳市沈北新区辉山经济开发区沈北路176号

Manufacturing Company

Company Name原研药港生物制药（沈阳）股份有限公司

Company Address

沈阳市浑南区麦子屯603-10号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.